A comparative analysis of various cannabinoids in the medicinal versus the pharmaceutical markets. The session will include variability in dosing and titration, side effect and tolerability profile as well as patient experience in each instance. Single molecular efficacy versus the entourage effect and a brief overview of cannabinoids currently used in treating patients will be addressed.